T
Thibault Moreau
Researcher at French Institute of Health and Medical Research
Publications - 195
Citations - 9443
Thibault Moreau is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Multiple sclerosis & Medicine. The author has an hindex of 37, co-authored 169 publications receiving 8290 citations. Previous affiliations of Thibault Moreau include University of Burgundy & University of Cambridge.
Papers
More filters
Journal ArticleDOI
Rate of Pregnancy-Related Relapse in Multiple Sclerosis
Christian Confavreux,Michael Hutchinson,Martine Hours,Cortinovis-Tourniaire P,Thibault Moreau +4 more
TL;DR: This study studied 254 women with multiple sclerosis during 269 pregnancies in 12 European countries to determine the rate of relapse per trimester and the score on the Kurtzke Expanded Disability Status Scale.
Journal ArticleDOI
Relapses and progression of disability in multiple sclerosis.
TL;DR: The time course of progressive, irreversible disease among patients with the primary progressive type of multiple sclerosis was not affected by the presence or absence of superimposed relapses.
Journal ArticleDOI
Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse.
Sandra Vukusic,Michael Hutchinson,Martine Hours,Thibault Moreau,Cortinovis-Tourniaire P,Patrice Adeleine,Christian Confavreux +6 more
TL;DR: The 2-year post-partum follow-up and an analysis of clinical factors which might predict the likelihood of a relapse in the 3 months after delivery confirm that the relapse rate remains similar to that of the pre-pregnancy year, after an increase in the first trimester following delivery.
Journal ArticleDOI
Rate of Pregnancy-Related Relapse in Multiple Sclerosis
Christian Confavreux,Michael Hutchinson,Martine Hours,Cortinovis-Tourniaire P,Thibault Moreau +4 more
TL;DR: In women with multiple sclerosis, the rate of relapse declines during pregnancy, especially in the third trimester, and increases during the first three months post partum before returning to the prepregnancy rate.
Journal ArticleDOI
Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study.
Alvaro Cobo-Calvo,Anne Ruiz,Elisabeth Maillart,Bertrand Audoin,Hélène Zéphir,Bertrand Bourre,Jonathan Ciron,Nicolas Collongues,David Brassat,François Cotton,Caroline Papeix,Françoise Durand-Dubief,David Laplaud,Romain Deschamps,Mikael Cohen,Damien Biotti,Xavier Ayrignac,Caroline Tilikete,Eric Thouvenot,Bruno Brochet,Cécile Dulau,Thibault Moreau,Ayman Tourbah,Pierre Lebranchu,Laure Michel,Christine Lebrun-Frenay,Alexis Montcuquet,Guillaume Mathey,Marc Debouverie,Jean Pelletier,Pierre Labauge,Nathalie Derache,M. Coustans,Fabien Rollot,Jérôme De Seze,Sandra Vukusic,Romain Marignier +36 more
TL;DR: In adults, MOG-Ab-associated disease extends beyond clinical and radiologic abnormalities in the optic nerve and spinal cord and despite the relapsing course, the overall visual and motor outcome is better compared with AQP4- Ab-positive patients.